Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 13,139 shares at $25.17 ($330K) on 2022-02-18, disclosed to the SEC on 2022-02-23.
Seasonal sale ($330k) by EVP R&D, Chief Medical Officer — this insider has traded ALKS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.17 | 2,306 | $58K | 17.6% |
| 2 | $25.17 | 2,306 | $58K | 17.6% |
| 3 | $25.08 | 2,966 | $74K | 22.6% |
| 4 | $25.08 | 2,022 | $51K | 15.4% |
| 5 | $25.01 | 3,539 | $89K | 26.8% |
| Total | $25.09 avg | 13,139 |
| $330K |
| 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |